Skip to content

Effects of Instrument Assisted Soft Tissue Mobilization on Healthy Tissue Regarding Range of Motion and Gait

Effects of Instrument Assisted Soft Tissue Mobilization on Healthy Tissue Regarding Range of Motion and Gait

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06612983
Acronym
(IASTM)
Enrollment
70
Registered
2024-09-25
Start date
2023-01-09
Completion date
2023-02-28
Last updated
2024-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Instrument assisted soft tissue mobilization, Range of Motion, Gait

Brief summary

The goal of this clinical trial is to study the effects of instrument assisted soft tissue mobilization (IASTM) in healthy tissue of adult volunteers. The main questions it aims to answer are: * Does IASTM treatment have an effect on range of motion (ROM) as measured in the ankle and knee? * Does IASTM treatment have an effect on movement patterns including gait - how a person walks? Researchers will compare pre-test and post-test data from the same individual on their day with treatment to the pre-test and post-test data from the same individual on their day without treatment to see if ROM or gait are effected by use of IASTM. Participants will: * Complete a past medical and injury history questionnaire * Have ankle and knee range of motion (ROM) measurements taken on both lower extremities using a goniometer * Undergo a gait analysis to determine center of gravity, center of pressure, step length, stride length, and stride frequency using Noraxon MyoMuscle Ultium Insoles * Undergo IASTM treatment techniques using the HawkGrips tools including applying emollient to the skin to reduce friction on the surface followed by scanning the gastroc/soleus complexes and Achilles tendons using the HG8-Scanner tool for 15 strokes in each direction to identify areas of concern, then the concave tool corresponding to the size of the structure being treated will be used (HG6-Large Multi-Curve, HG5-Medium Multi-Curve, HG4-Small Multi-Curve) for 15 strokes in each direction. Treatment techniques should last for 10 minutes in total on each side. * Complete the ankle and knee ROM measurements as well as gait analysis again to document progress at the end of the first session. * Return three to seven days after the first session in which the subject will have the walking treatment. * Undergo the same baseline pre-test measurements for range of motion and gait analysis as the first session * Experience the walking treatment by walking for the same time period that the IASTM treatment took at the first session * Undergo the post-test range of motion and gait analysis for data comparison.

Detailed description

No further information to note than what is described in the summary or elsewhere

Interventions

OTHERInstrument Assisted Soft Tissue Mobilization

Instrument assisted soft tissue mobilization is a technique that is applied using specially designed tools/instruments to provide a mobilizing effect to soft tissues including the skin, fascia, muscles, and tendons by its various direct compressive stroke techniques on the gastroc/soleus complexes and Achilles tendons in the first session.

OTHERWalking Treatment

Movement itself should promote mobility so walking steadily for the same period of time as the IASTM had taken to complete is the sham treatment in second session.

Sponsors

Minot State University
CollaboratorOTHER
Beth Marschner
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

All participants will experience the IASTM treatment first and the first session and the walking - sham treatment at the second session.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Individuals from a small regional university student body, faculty and staff may choose to volunteer to participate in this study.

Exclusion criteria

* Acute spinal cord injury with neurological deficits * Neurological disorders * Acute lower extremity injury such as sprain or strain * Acute lower extremity pain causing gait deviation * Any type of lower extremity fracture within the past 12 months * Lumbar disc pathology with radicular symptoms * Use of blood thinning or clotting medications * Known connective tissue disorder

Design outcomes

Primary

MeasureTime frameDescription
Range of MotionFrom baseline to end of session at one hourBilateral knee flexion and extension as well as ankle plantarflexion, dorsiflexion, inversion and eversion range of motion measurements were taken in supine using a goniometer.
GaitFrom baseline to end of session at one hourGait analysis was conducted using Noraxon MyoMuscle System with Ultium insoles placed in the participants shoes. The software collected data on center of gravity, center of pressure, step length, stride length, and stride frequency.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026